Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.70 |
| ▸ | LPL | P06858 | 12/20 | 0.70 |
| ▸ | P4HB | P07237 | 1/20 | 0.42 |
| ▸ | PNMT | P11086 | 1/20 | 0.41 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA3 | P07451 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.38 |
| ▸ | F11 | P03951 | 1/20 | 0.37 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21043068 | 0.97 | LIPG (0.75) | LIPGLPLP4HBPNMTDGAT1 | |
| SCHEMBL21042626 | 0.97 | LIPG (0.75) | LIPGLPLP4HBPNMTDGAT1 | |
| SCHEMBL19831191 | 0.95 | LIPG (0.61) | LIPGLPLP4HBPNMTCA1 | |
| SCHEMBL19831185 | 0.89 | LIPG (0.57) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL21935646 | 0.89 | LIPG (0.57) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL19831000 | 0.89 | LIPG (0.57) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL19830980 | 0.88 | LPL (0.53) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL21042129 | 0.86 | LIPG (0.54) | LIPGLPLP4HBCA1CA2 | |
| SCHEMBL21042549 | 0.86 | LIPG (0.76) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL21042621 | 0.86 | LIPG (0.51) | LIPGLPLP4HBPNMTDGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3487864-B1 | METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2020-04-29 | — | — | EP | disclosed |
| US-20190161510-A1 | METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2019-05-30 | — | — | US | disclosed |
| WO-2018019688-A1 | METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2018-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190161510-A1 | METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENCE DEVICES | MCU, AP3M1, AP2M1 | LIPG 3307/4885LPL 3527/4885P4HB 3433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.